期刊文献+

马来酸依那普利叶酸片对H型高血压患者的疗效观察 被引量:13

THE CURATIVE EFFECT OF MALEIC ACID ENALAPRILAT FOLIC ACID TABLETS IN H HYPERTENSIVE PATIENTS
原文传递
导出
摘要 目的观察马来酸依那普利叶酸片对伴有同型半胱氨酸(Hcy)升高的高血压患者的疗效。方法选择230例伴有血浆同型半胱氨酸升高的原发性高血压患者,随机分为观察组(马来酸依那普利叶酸片10mg+0.8mg)和对照组(马来酸依那普利10mg),总观察治疗时间为36周。评价指标有:血压水平、血浆Hcy、尿白蛋白/肌酐比值(A/C)、颈动脉内膜厚度(IMT)。结果治疗前观察组与对照组在血压水平、Hcy、尿A/C、IMT差异无统计学意义。用药治疗36周后观察组与对照组在收缩压(SBP)与舒张压(DBP)水平的控制上差异有统计学意义(P<0.05);对于血浆Hcy的控制上观察组与对照组差异有统计学意义(P<0.01);在尿A/C比值水平的控制上观察组与对照组差异有统计学意义(P<0.01);对于IMT的控制上观察组与对照组差异有统计学意义(P<0.01)。结论马来酸依那普利叶酸片对于伴有血浆Hcy水平升高的高血压患者(H型高血压)的血压水平、血浆Hcy、尿A/C比值、IMT均有明显的改善,延缓了动脉粥样硬化的进展,保护了靶器官的功能。 Objective To observe the therapeutic effect of malay acid enalaprilat folic acid tablets in hyper- tensive patients accompanied by elevated homocysteine(Hcy). Methods Total 230 patients with elevated plasma homocysteine in essential hypertension patients were randomly divided into experimental group (ma- leic acid enalaprilat folic acid tablets 10 mg + 0.8 mg) and control group (maleic acid enalaprilat 10 mg), all subjects were followed- up 36 weeks. Evaluation indexes included blood pressure, plasma homocysteine levels, the urinary albumin/creatinine ratio (A/C), carotid intimal thickness (IMT). Results Some inde- xes such as blood pressure, plasma homocysteine levels, the urinary albumin/creatinine ratio, carotid ar- tery intima thickness in experimental group and control group before treatment were no statistical differ- ence. On the control level of systolic blood pressure (SBP) and diastolic blood pressure (DBP) was statisti- cally difference after 36 weeks drug treatment in experimental group and control group(P d0.05) ; the lev- el of plasma homocysteine in experimental group was lower than control group(P d0.01). Urinary albu- min/creatinine ratio of trial group and control group was statistically difference (P d0.05), and carotid ar- tery intima thickness of experimental group and control group was also statistically difference (P d0.01). Conclusions For the hypertensive patients accompanied by elevated plasma homocysteine, maleic acid enal- aprilat folic acid tablets can obvious decreased the level of blood pressure and blood plasma homocysteine, optimize the urinary albumin/creatinine ratio, improve the thickness of the carotid artery intima, delay the progression of atherosclerosis, protect the function of target organs.
作者 李莉 李学奇
出处 《中国煤炭工业医学杂志》 2013年第4期524-527,共4页 Chinese Journal of Coal Industry Medicine
关键词 马来酸依那普利叶酸片 高血压 血浆同型半胱氨酸 尿白蛋白 肌酐比值 颈动脉 内膜厚度 Maleic acid enalaprilat folic acid tablets~ Hypertension~ Plasma homocysteine Urine albumin/creatinine ratio~ Carotid intima thickness
  • 相关文献

参考文献12

二级参考文献46

  • 1饶明俐.《中国脑血管病防治指南》摘要(一)[J].中风与神经疾病杂志,2005,22(5):388-393. 被引量:215
  • 2汪旭,薛京伦.叶酸代谢与人类基因组稳定性的关系研究进展[J].国外医学(遗传学分册),2005,28(5):257-261. 被引量:17
  • 3顾东风,Jiang He,吴锡桂,段秀芳,姚崇华,王家良,Kristi Reynolds,Chung-Shiuan Chen,Michael J.Klag,Paul K.Whelton.中国成年人主要死亡原因及其危险因素[J].中国慢性病预防与控制,2006,14(3):149-154. 被引量:76
  • 4Hostetter TH. Prevention of the development and progression of renal desease. J Am Soc Nephrol,2003,147 Suppl 2:144-147.
  • 5Clark R, Daly L, Robinson K, et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med, 1991,324 : 1149-1155.
  • 6Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atheroselerosis, 1993, 103 : 149-157.
  • 7Buysschaert M, Dramais AS, Wallemacq PE,et al. Hyperhomocysteinemia in Type 2 Diabetes: Relationship to maeroangiopathy, nephropathy, and insulin resistance. Diabetes Care,2000, 23:1816-1822.
  • 8Aso Y, Yoshida N, Okumura K, et al. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia. Clinica Chimica Acta, 2004, 348:139-145.
  • 9Brazionis L, Rowley K, Itsiopoulos C, et al. Homocysteine and diabetic retinopathy. Diabetes Care, 2008, 31 : 50-56.
  • 10Mann JFE, Sheridan P, McQueen M J, et al. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease-results of the renal Hope-2 study. Nephrol Dial Transplant, 2008, 23: 645-653.

共引文献455

同被引文献136

  • 1郑卫峰,王晓阳,张守彦.冠心病患者IVUS-VH下斑块性质与H型高血压的关系[J].中国动脉硬化杂志,2015,23(1):78-82. 被引量:7
  • 2顾玥.高血压病的健康教育[J].中国心血管病研究,2005,3(6):479-480. 被引量:23
  • 3张素荣,陈志刚,吕风华,张永春,李红军,袁宇,黄陆力,张卫国.不同剂量叶酸、B族维生素对冠心病患者血浆同型半胱氨酸的影响[J].中国心血管病研究,2006,4(7):493-494. 被引量:7
  • 4李建平,霍勇,刘平,秦献辉,关德明,葛均波,胡健,王燕妮,张馥敏,毛广运,徐希平.马来酸依那普利叶酸片降压、降同型半胱氨酸的疗效和安全性[J].北京大学学报(医学版),2007,39(6):614-618. 被引量:394
  • 5Dominguez-godriguez A,Abreu qonzalez P,et aI.Does ischemia-modified albumin add prognostic value to the Thrombolysis in Myocardial Infarction risk score in patients with ST-segment elevation myocardial infarctiontreated with primary ng op aty[J]. B iomarkers,2009,21 (2).42-44.
  • 6Y.Huo,X.Qin,J.Wang. Efficacy of folic acid supplementation in stroke prevention:new insight from a meta analysis[J].lntenational Journal of Clinical Practice,2012,36(6):421-423.
  • 7Xianhui Qin,Jianping Li,Yimin. Effect of foiic acid intervention on the change of serum folate level in hypertensive Chinese adults:do methylenetetrahydrofolate reductase and methionine synthase genepolymorphisms &ffect ther&peutic responses[J].Ph&rmacogenetics &nd Genomics, 2012,35(6): 56-57.
  • 8张红雨.马来酸依那普利叶酸片降压及降同型半胱氨酸的临床应用研究.桂林医学院,2012.
  • 9Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Con- trol Clin Trials, 1996,17:1-12.
  • 10Lonn E, Yusuf S, Amold M J, et al. Honlocysteine lowering with folic acid and B vitamins in vascular disease. N End J Med, 2006,354 : 1567-1577.

引证文献13

二级引证文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部